AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9759611
Drug: Heparin (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin (0.2 U/ml)
Trial: 7886407
Drug: Furosemide with
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide with placebo pre-treatment
Trial: 7886407
Drug: Furosemide with
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide with captopril pre-treatment
Trial: 7886407
Drug: Furosemide with
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide with prazosin pre-treatment
Trial: 3229117
Drug: Small doses
RxNorm normalized name: smallpox vaccine live, New York City Board of Health vaccinia strain Injectable Solution [ACAM2000]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small doses of heparin (2 X 5000 u. subcutaneously/24 h)
Trial: 31984443
Drug: Insulin degludec
RxNorm normalized name: Insulin Degludec
DrugBank: Insulin degludec (DB09564)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Insulin degludec 200 U/ml (degludec U200)
Trial: 31984443
Drug: Insulin glargine
RxNorm normalized name: Insulin Glargine
DrugBank: Insulin glargine (DB00047)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Insulin glargine 300 U/ml (glargine U300)
Trial: 30497483
Drug: Chuna manual
RxNorm normalized name: China-Gel
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chuna manual therapy (10 sessions, twice a week for 5 weeks)
Trial: 30497483
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (conventional physical therapy and medication treatment)
Trial: 30497483
Drug: Chuna manual
RxNorm normalized name: China-Gel
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chuna manual therapy
Trial: 25155416
Drug: Acid infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acid infusion into the distal esophagus
Trial: 25953832
Drug: Intranasal scopolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal scopolamine (0.4 mg)
Trial: 26268532
Drug: Intranasal scopolamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal scopolamine
Trial: 18296328
Drug: 50mg L-theanine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50mg L-theanine
Trial: 15642700
Drug: Nebivolol (titrated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (titrated from 1.25 mg once daily to 10 mg once daily, mean maintenance dose 7.7 mg)
Trial: 15642700
Drug: Placebo (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (mean maintenance dose 8.5 mg)
Trial: 10666558
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg of haloperidol
Trial: 29170792
Drug: 5% prilocaine/lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% prilocaine/lidocaine (EMLA) cream
Trial: 29170792
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg indomethacin suppository
Trial: 25680360
Drug: Medication only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication only users
Trial: 25680360
Drug: Participants not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Participants not utilizing medications or psychotherapy
Trial: 23690342
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blocker treatment
Trial: 20427734
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (45 mg zinc/d as gluconate for 6 months)
Trial: 18987396
Drug: Topical hemostasis
RxNorm normalized name: collagen hemostat Topical Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical hemostasis patch (SafeSeal Patch, Possis Medical Inc.) with manual pressure
Trial: 16635793
Drug: Thymoglobulin (THY)
RxNorm normalized name: Thymoglobulin
DrugBank: Antithymocyte immunoglobulin (rabbit) (DB00098)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thymoglobulin (THY) 4.5 to 6.0 mg/kg
Trial: 12825855
Drug: Fulvestrant 250
RxNorm normalized name: fulvestrant 250 MG in 5 ML Prefilled Syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fulvestrant 250 mg as a monthly intramuscular injection followed by subsequent endocrine therapy
Trial: 12825855
Drug: Subsequent endocrine
RxNorm normalized name: ENDOCRINE THERAPY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subsequent endocrine therapy after no clinical benefit from fulvestrant
Trial: 11023930
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus injection of 5 mg of P5 variant
Trial: 11023930
Drug: Intravenous bolus
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous bolus injection of 2.5 mg of P10 variant
Trial: 8828024
Drug: Ebastine 10mg
RxNorm normalized name: ebastine
DrugBank: Ebastine (DB11742)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebastine 10mg once daily
Trial: 8828024
Drug: Terfenadine 60mg
RxNorm normalized name: TERFENADINE 60MG TAB
DrugBank: Terfenadine (DB00342)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terfenadine 60mg twice daily
Trial: 21492763
Drug: MitraClip treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MitraClip treatment
Trial: 28973174
Drug: Low-dose alteplase
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose alteplase
Trial: 28973174
Drug: Standard-dose alteplase
RxNorm normalized name: Alteplase
DrugBank: Alteplase (DB00009)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard-dose alteplase
Trial: 23575879
Drug: Oral omega-3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral omega-3 fatty acids supplements for 12 weeks
Trial: 22594137
Drug: Propranolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40 mg twice daily)
Trial: 22594137
Drug: Placebo (lactose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (lactose pill twice daily)
Trial: 18301124
Drug: quetiapine XR
RxNorm normalized name: quetiapine Extended Release Oral Tablet
DrugBank: Quetiapine (DB01224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: quetiapine XR (once-daily equivalent dose)
Trial: 18301124
Drug: quetiapine IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: quetiapine IR (twice-daily)
Trial: 10699894
Drug: Chemotherapy based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy based on the combination of cisplatin and etoposide
Trial: 10699894
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and PC resection
Trial: 9068554
Drug: Gastrointestinal lavage
RxNorm normalized name: lovage oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastrointestinal lavage solution (3 L)
Trial: 8403120
Drug: Parenteral analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral analgesia with morphine
Trial: 31931550
Drug: Chemoprophylaxis with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemoprophylaxis with 2.5 mg fondaparinux for 5 days postoperatively
Trial: 29575241
Drug: Supported self‐management
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supported self‐management delivered by diabetes specialist nurses plus treatment as usual
Trial: 21189774
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg) and submucosal fentanyl (3 microg/kg)
Trial: 21189774
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg) and submucosal placebo
Trial: 12707646
Drug: Active antigenic
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active antigenic suspension
Trial: 8823335
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus pamidronate 45 mg in 250 mL of saline as a 1‐hour intravenous infusion every 3 weeks
Trial: 8823335
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus pamidronate
Trial: 1418071
Drug: Pirenzepine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pirenzepine (100 mg/d)
Trial: 3965269
Drug: Domperidone (chronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone (chronic administration, 35‐51 days)
Trial: 30021756
Drug: Natural S-equol
RxNorm normalized name: S-equol
DrugBank: Equol (DB11674)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Natural S-equol supplement (10 mg a day, orally, twice daily for three menstrual cycles)
Trial: 30021756
Drug: Placebo (orally,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (orally, twice daily for three menstrual cycles)
Trial: 25633713
Drug: Low-dose CpG-B
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CpG-B + GM-CSF
Trial: 28972083
Drug: Low-dose CpG-B
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CpG-B
Trial: 22985432
Drug: dexpramipexole 300
RxNorm normalized name: Dexpramipexole
DrugBank: Dexpramipexole (DB15130)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexpramipexole 300 mg/day
Trial: 22985432
Drug: dexpramipexole 50
RxNorm normalized name: Dexpramipexole
DrugBank: Dexpramipexole (DB15130)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: dexpramipexole 50 mg/day
Trial: 18239661
Drug: Methylphenidate hydrochloride
RxNorm normalized name: Methylphenidate Hydrochloride
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate hydrochloride (MPH) 0.5 mg/kg
Trial: 16357400
Drug: Group 2
RxNorm normalized name: Chlamydophila psittaci biogroup 2 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 2 (fixed-duration injection protocol, 38 sec duration)
Trial: 16357400
Drug: Group 1
RxNorm normalized name: Chlamydophila psittaci biogroup 1 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1 (fixed-rate injection protocol, 3 or 4 mL/sec)
Trial: 16357400
Drug: Group 3
RxNorm normalized name: Chlamydophila psittaci biogroup 3 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 3 (fixed-duration injection protocol, 47 sec duration)
Trial: 3009368
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of irradiation
Trial: 31439367
Drug: Uncemented press-fit
RxNorm normalized name: garden cress sprout extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uncemented press-fit Regenerex® Porous Titanium Construct tibial tray and matching cemented patella and femoral components (hybrid implant)
Trial: 28056024
Drug: Single-dose 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose 400 mg albendazole
Trial: 23908568
Drug: Bevacizumab (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (2.5 mg)
Trial: 23908568
Drug: Ranibizumab (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranibizumab (1 mg)
Trial: 11351141
Drug: Cholinesterase inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholinesterase inhibitors (ChE‐Is) including donepezil
Trial: 8195995
Drug: Composite resin‐glass
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Composite resin‐glass ionomer hybrid with a dentinal bonding agent
Trial: 3370922
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg of alpha‐methyldopa
Trial: 3370922
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of alpha‐methyldopa
Trial: 10952746
Drug: Radon and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radon and carbon dioxide baths (1.3 kBq/l, 1.6 g carbon dioxide/l on average)
Trial: 8828098
Drug: Endotoxin administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Endotoxin administration (Escherichia coli, Lot EC‐5, 4 ng/kg)
Trial: 8828098
Drug: Antiendotoxin molecules
RxNorm normalized name: Molecular AF
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Antiendotoxin molecules
Trial: 8828098
Drug: Mediator receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mediator receptor antagonist
Trial: 8828098
Drug: Antimediator therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimediator therapy
Trial: 271585
Drug: Anti-inflammatory agents
RxNorm normalized name: Surpass Anti-Inflammatory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-inflammatory agents
Trial: 1580285
Drug: Perindopril (4-8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (4-8 mg/day)
Trial: 6342352
Drug: Metoprolol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (15 mg intravenously followed by 200 mg daily orally for 3 months)
Trial: 30833491
Drug: Intravenous methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous methylprednisolone (250 mg at anesthetic induction and 250 mg at initiation of cardiopulmonary bypass)
Trial: 28685884
Drug: Recent Injection
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Recent Injection Drug Use (IDU)
Trial: 25187158
Drug: Biological treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biological treatment (specifics not provided)
Trial: 23981692
Drug: Intravenous tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous tranexamic acid 1 g 10‐min bolus followed by 1 g eight‐hour infusion
Trial: 15063813
Drug: Pamidronate (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pamidronate (30 mg per treatment) given at 3-month intervals for 12 months
Trial: 11590925
Drug: Triple-drug regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-drug regimen with abacavir
Trial: 11590925
Drug: PI-containing triple-drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PI-containing triple-drug combinations
Trial: 8149030
Drug: Single 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 1.5 gram dose of cefuroxime plus three doses of placebo
Trial: 8149030
Drug: Four 1
RxNorm normalized name: Wal-Four 1% Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four 1 gram doses of cefazolin
Trial: 25117066
Drug: PK-guided 5-FU
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: PK-guided 5-FU dosing
Trial: 22985896
Drug: 2% chlorhexidine
RxNorm normalized name: CHLORHEXIDINE GLUCONATE 1.2 [iU] in 1 mL BUCCAL MOUTHWASH [0.12% Chlorhexidine Gluconate Oral Rinse]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% chlorhexidine gel (CLX)
Trial: 15830986
Drug: Intradiscal ozone
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradiscal ozone injection
Trial: 15830986
Drug: Microdiscectomy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microdiscectomy and Intradiscal ozone injection
Trial: 10348358
Drug: Alpha-adrenergic blocking
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpha-adrenergic blocking agent (phentolamine mesylate, 20 ml infused at 2 ml/min)
Trial: 10348358
Drug: Placebo (physiological
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (physiological saline, 20 ml infused at 2 ml/min)
Trial: 1940488
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg oral morphine in fasted state
Trial: 1940488
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg oral morphine in fed state
Trial: 26313229
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg BR-DIM, twice daily
Trial: 26313229
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg BR-DIM, twice daily
Trial: 26313229
Drug: Placebo, twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, twice daily
Trial: 26313229
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg BR-DIM, twice daily
Trial: 15144473
Drug: Myrmecia pilosula
RxNorm normalized name: Codonopsis pilosula root extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myrmecia pilosula ant venom immunotherapy (VIT)
Trial: 26054104
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis in UHR
Trial: 21321152
Drug: Low-gradient severe
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-gradient severe aortic stenosis with reduced stroke volume index (≤ 35 mL/m²)
Trial: 16864815
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A (BTXA) 50 units/0.25 mL
Trial: 16864815
Drug: Isotonic saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic saline (0.25 mL)
Trial: 12615873
Drug: Beta-lactam therapy
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-lactam therapy (including cefuroxime and amoxicillin)
Trial: 12615873
Drug: Beta-lactam therapy
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-lactam therapy
Trial: 10844622
Drug: Essential amino
RxNorm normalized name: Essential amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential amino acids (EAAs) 3.6 g three times daily with meals for three months
Trial: 9228227
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy with additional ultrasound treatment for 12 weeks (30 kHz continuous ultrasound 100 mW/cm2 three times a week)
Trial: 9228227
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy with topical application of hydrocolloid dressings and compression therapy
Trial: 1859751
Drug: Edrophonium 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edrophonium 1.0 mg kg‐1
Trial: 29334721
Drug: Tocilizumab (TCZ)
RxNorm normalized name: Tocilizumab
DrugBank: Tocilizumab (DB06273)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tocilizumab (TCZ) 8 mg/kg intravenously every 4 weeks
Trial: 23546863
Drug: Transfixion and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transfixion and excision of the sac in the traditional manner (Group L)
Trial: 12445840
Drug: Low-dose prednisone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose prednisone (initial dose: 20 mg/day, maintenance dose: 10 mg/day)
Trial: 1279928
Drug: Infusions of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusions of dextran-40 with pentoxifylline
Trial: 1279928
Drug: Saline infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusions with pentoxifylline
Trial: 1279928
Drug: Saline infusions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline infusions with placebo medication
Trial: 6428171
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with verapamil (360 mg daily) and atenolol (100 mg daily)
Trial: 6428171
Drug: Single drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single drug therapy (either verapamil or atenolol)
Trial: 3094443
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil (1.5 g) with probenecid (1 g)
Trial: 3094443
Drug: Amoxicillin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (3 g) with probenecid (1 g)
Trial: 31983031
Drug: Standard-of-care medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-of-care medical treatment (control)
Trial: 25707509
Drug: IgE antibodies
RxNorm normalized name: digoxin antibodies Fab fragments Injection [DigiFab]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgE antibodies to hazelnut components (Cor a 9 and Cor a 14)
Trial: 30379222
Drug: Goal-directed therapy
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goal-directed therapy group
Trial: 19415350
Drug: G-Cem (GC)
RxNorm normalized name: CEM-Urea
DrugBank: Urea (DB03904)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: G-Cem (GC)
Trial: 18209581
Drug: PPI (rabeprazole,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PPI (rabeprazole, lansoprazole, or omeprazole) plus amoxicillin and metronidazole given b.i.d. for 7 days
Trial: 17000910
Drug: Atorvastatin 40
RxNorm normalized name: atorvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 40 mg/d and Placebo
Trial: 14624763
Drug: Three times
RxNorm normalized name: WELLBUTRIN 100 MG Oral Tablet, Three Times Daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Three times weekly GH injections